CCNE1 amplification is associated with poor prognosis in patients with triple negative breast cancer

BACKGROUND: Triple negative breast cancer (TNBC) is aggressive with limited treatment options upon recurrence. Molecular discordance between primary and metastatic TNBC has been observed, but the degree of biological heterogeneity has not been fully explored. Furthermore, genomic evolution through t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zi-Ming, Yost, Susan E., Hutchinson, Katherine E., Li, Sierra Min, Yuan, Yate-Ching, Noorbakhsh, Javad, Liu, Zheng, Warden, Charles, Johnson, Radia M., Wu, Xiwei, Chuang, Jeffrey H., Yuan, Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341717/
https://www.ncbi.nlm.nih.gov/pubmed/30665374
http://dx.doi.org/10.1186/s12885-019-5290-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341717/
https://www.ncbi.nlm.nih.gov/pubmed/30665374
http://dx.doi.org/10.1186/s12885-019-5290-4

Ejemplares similares